Back to Journals » Patient Preference and Adherence » Volume 6

Corrigendum

Authors Santana L, Fontenelle L

Received 15 February 2012

Accepted for publication 15 February 2012

Published 27 February 2012 Volume 2012:6 Pages 153—154

DOI https://doi.org/10.2147/PPA.S30896



Santana L, Fontenelle LF. A review of studies concerning treatment adherence of patients with anxiety disorders. Patient Preference and Adherence. 2011;5:427–439.

1. On page 432, row 3, column 7 of Table 4 (Mancebo et al, Cognitive predictors of adherence) should be:

Patients who reported not adhering to medication described that different factors influenced their decision, including disliking medication side effects, feeling too anxious/fearful of taking medication, and perceiving treatment as not useful. Patients who described not adhering to CBT reported a number of perceived environmental barriers, such as lack of time, no money to pay for therapy, or not having CBT available.

2. On page 438, column 1, paragraph 2 under the heading OCD should be:

Mancebo et al14 found that, of the 22 patients with OCD who did not adhere to CBT, 50% reported perceived environmental barriers, including being too busy or feeling that treatment was inconvenient, not having enough money to pay for CBT, not possessing a health insurance plan that covered CBT, and not having CBT available. Conversely, of the 46 patients with OCD who reported medication nonadherence, 78.3% described disliking side effects, 41.3% argued that they were feeling too anxious/fearful of taking medication, and 41.3% perceived treatment as not useful.

Read the original article

Creative Commons License © 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.